These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6291904)

  • 21. Comparative effects of Des Leu Angiotensin I and Angiotensin II on AVP secretion from the hypothalamoneurohypophysis and pituitary of the rat.
    Hebden RA; Claybaugh JR; Hashiro GM
    Life Sci; 1992; 51(3):195-202. PubMed ID: 1614285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Facilitation by forskolin of electrically evoked vasopressin release in vitro requires bursting pattern of stimulation.
    Treiman M; Allesøe K; von Spreckelsen S
    Brain Res; 1989 May; 488(1-2):260-4. PubMed ID: 2545302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blocking central leukotrienes synthesis affects vasopressin release during sepsis.
    Athayde LA; Oliveira-Pelegrin GR; Nomizo A; Faccioli LH; Rocha MJ
    Neuroscience; 2009 Jun; 160(4):829-36. PubMed ID: 19285113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative studies on the release of vasopressin and 7B2 from isolated hypothalami.
    Venetikou MS; Lacoumenta S; Ghatei MA; Burrin JM; Bloom SR
    Regul Pept; 1990 Jul; 29(2-3):163-72. PubMed ID: 2217901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the neuroendocrine role of serotonin.
    Jørgensen HS
    Dan Med Bull; 2007 Nov; 54(4):266-88. PubMed ID: 18208678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. kappa-Opioid agonist inhibition of osmotically induced AVP release: preferential action at hypothalamic sites.
    Rossi NF; Brooks DP
    Am J Physiol; 1996 Feb; 270(2 Pt 1):E367-72. PubMed ID: 8779961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyrotropin-releasing hormone (TRH) and vasopressin and oxytocin release: in vitro as well as in vivo studies.
    Ciosek J; Guzek JW
    Exp Clin Endocrinol; 1992; 100(3):152-9. PubMed ID: 1305067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of stress on the hypothalamic and neurohypophysial vasopressin content and plasma renin activity in rats.
    Olczak S; Guzek JW
    Acta Physiol Pol; 1983; 34(1):47-55. PubMed ID: 6356787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
    Kumari M; Cover PO; Poyser RH; Buckingham JC
    Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ca2+ clearance mechanisms in neurohypophysial terminals of the rat.
    Sasaki N; Dayanithi G; Shibuya I
    Cell Calcium; 2005 Jan; 37(1):45-56. PubMed ID: 15541463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
    Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
    J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasopressin and oxytocin release as influenced by thyrotropin-releasing hormone in euhydrated and dehydrated rats.
    Ciosek J
    J Physiol Pharmacol; 2002 Sep; 53(3):423-37. PubMed ID: 12369739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histaminergic and catecholaminergic interactions in the central regulation of vasopressin and oxytocin secretion.
    Knigge U; Willems E; Kjaer A; Jørgensen H; Warberg J
    Endocrinology; 1999 Aug; 140(8):3713-9. PubMed ID: 10433231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apelin-13 and APJ in paraventricular nucleus contribute to hypertension via sympathetic activation and vasopressin release in spontaneously hypertensive rats.
    Zhang F; Sun HJ; Xiong XQ; Chen Q; Li YH; Kang YM; Wang JJ; Gao XY; Zhu GQ
    Acta Physiol (Oxf); 2014 Sep; 212(1):17-27. PubMed ID: 24995933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of i.c.v. losartan on the angiotensin II-mediated vasopressin release and hypothalamic fos expression in near-term ovine fetuses.
    Shi L; Mao C; Wu J; Morrissey P; Lee J; Xu Z
    Peptides; 2006 Sep; 27(9):2230-8. PubMed ID: 16677737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of cholinergic antagonists on basal and osmotically stimulated vasopressin release in compartmentalized hypothalamo-neurohypophysial explants.
    Gregg CM
    Neuroendocrinology; 1986; 44(3):378-83. PubMed ID: 2880306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of physical training by swimming on the arterial pressure, plasma and hypothalamo-post-hypophyseal vasopressin in genetically hypertensive rats of the Lyon strain].
    Ghaemmaghami F; Favier R; Gauquelin G; Allevard AM; Desplanches D; Vincent M; Sassard J; Legros JJ; Gharib C
    C R Seances Soc Biol Fil; 1985; 179(2):209-17. PubMed ID: 3160440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of nitric oxide synthase inhibitors on the vasopressin-induced pituitary-adrenocortical activity and hypothalamic catecholamine levels.
    Bugajski J; Gadek-Michalska A; Głód R; Borycz J
    J Physiol Pharmacol; 1998 Dec; 49(4):617-26. PubMed ID: 10069702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Control of posterior pituitary vasopressin content: implications for the regulation of the vasopressin gene.
    Fitzsimmons MD; Roberts MM; Robinson AG
    Endocrinology; 1994 Apr; 134(4):1874-8. PubMed ID: 8137755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of vasopressin release from the neurohypophysis by the intact neuron.
    Mathison R; Lederis K
    Proc West Pharmacol Soc; 1978; 21():257-60. PubMed ID: 211528
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.